# Dienogest

## Visanne 2mg

| 藥物代碼 | OVIS2 |
| :--- | :--- |
| 適應症 | Management of pelvic pain associated with endometriosis. |
| 副作用 | 1% to 10%:Central nervous system: Headache \(7%\), depression \(3%\), disturbed sleep \(2%\), irritability \(1%\), migraine \(1%\), nervousness \(1%\)Dermatologic: Acne vulgaris \(2%\), alopecia \(1%\)Endocrine & metabolic: Breast changes \(discomfort: 5%\), weight gain \(4%\), ovarian cyst \(3%\), decreased libido \(2%\)Gastrointestinal: Nausea \(4%\), abdominal pain \(2%\)Genitourinary: Vaginal hemorrhage \(1%\)Neuromuscular & skeletal: Weakness \(2%\)&lt;1%, postmarketing, and/or case reports: Abdominal distress, anemia, anxiety, back pain, breast induration, constipation, decreased glucose tolerance, dermatitis, diarrhea, disturbance in attention, dysautonomia, edema, feeling of heaviness \(extremities\), fibrocystic breast disease, flatulence, genital discharge, GI inflammation, hot flash, increased appetite, limb pain, lump in breast, mood changes, muscle spasm, onychoclasis, ostealgia, palpitations, pelvic pain, pruritus, skin pigmentation, skin photosensitivity, tinnitus, urinary tract infection, vulvovaginal candidiasis, vomiting, vulvar dryness, xeroderma, xerophthalmia. |
| 禁忌 | Hypersensitivity to dienogest or any component of the formulation; undiagnosed abnormal vaginal bleeding; active venous thromboembolic disorder; history of or current arterial and cardiovascular disease \(eg, MI, ischemic heart disease, cerebrovascular accident\); diabetes mellitus with vascular involvement; history of or current severe hepatic disease where liver function tests remain abnormal; history of or current hepatic neoplasia \(benign or malignant\); known or suspected sex-hormone-dependent malignancy; ocular lesions due to ophthalmic vascular disease, such as partial or complete vision loss or defect in visual fields; current or history of migraine with focal aura; breast-feeding; known or suspected pregnancy. |
| 藥物保存方式 | 室溫 |
| 用法用量 | Adult Endometriosis: Females: Oral: 2 mg once daily, taken preferably at the same time each day. |
| 肝功能異常 | 無需調整劑量  正在或曾經罹患重度肝臟疾病的患不建議使用 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 不可使用 |
| 孕期用藥建議 | N/A |
| 附帶說明 | Use is contraindicated during pregnancy. Based on limited data, inadvertent exposure in pregnancy has not shown adverse effects to the fetus.\(UpToDate\)2021/01/25 |
| 哺乳期用藥建議 | Unknown 尚未建立 |
| 附帶說明 | It is not known if dienogest is present in breast milk. Use is contraindicated in breastfeeding women. The risk of thromboembolism may be increased immediately postpartum.\(UpToDate\)2021/01/25 |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | Oral: Administer preferably at the same time each day with liquid and without regard to meals. Tablets should be taken continuously regardless of any vaginal bleeding. If vomiting and/or diarrhea occur within 3 to 4 hours of administration, repeat dose. |

